We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JSPR icon
3876
Jasper Therapeutics
JSPR
$20.2M
$32K ﹤0.01%
6,540
+3,680
+129% +$24.6K
JZXN icon
3877
Jiuzi Holdings
JZXN
$785K
$32K ﹤0.01%
29
+22
+314% +$41.6K
TIRX
3878
DELISTED
Tian Ruixiang Holdings
TIRX
$32K ﹤0.01%
680
-55
-7% -$3.58K
UPC icon
3879
Universe Pharmaceuticals Inc
UPC
$4.2M
$32K ﹤0.01%
6
ENSV
3880
DELISTED
Enservco Corp.
ENSV
$32K ﹤0.01%
+19,400
New +$40.5K
NTBL
3881
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$32K ﹤0.01%
7,557
-1,946
-20% -$9.15K
CELU icon
3882
Celularity
CELU
$19.1M
$31K ﹤0.01%
+2,380
New +$43.9K
ITRM
3883
DELISTED
Iterum Therapeutics
ITRM
$31K ﹤0.01%
37,084
+2,400
+7% +$3.41K
SNGX icon
3884
Soligenix
SNGX
$5.6M
$31K ﹤0.01%
284
+5
+2% +$722
WYY icon
3885
WidePoint Corp
WYY
$103M
$31K ﹤0.01%
16,900
+1,600
+10% +$3.52K
CRKN
3886
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
BFI
3887
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$31K ﹤0.01%
24,700
-8,020
-25% -$14.6K
LYT
3888
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
$31K ﹤0.01%
+895
New +$51.9K
LFLY
3889
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$31K ﹤0.01%
+2,350
New +$34.3K
HOOK
3890
DELISTED
HOOKIPA Pharma
HOOK
$30K ﹤0.01%
3,690
-10,530
-74% -$114K
OGEN icon
3891
Oragenics
OGEN
$2.39M
$30K ﹤0.01%
160
+31
+24% +$10.9K
SONX
3892
DELISTED
Sonendo, Inc.
SONX
$30K ﹤0.01%
+10,700
New +$20.2K
CEMI
3893
DELISTED
Chembio diagnostics, Inc.
CEMI
$30K ﹤0.01%
136,400
+22,800
+20% +$6.82K
BCDA icon
3894
BioCardia
BCDA
$12.4M
$29K ﹤0.01%
940
-13
-1% -$370
TPST icon
3895
Tempest Therapeutics
TPST
$14M
$29K ﹤0.01%
1,954
-123
-6% -$2.59K
BPTH
3896
DELISTED
Bio-Path Holdings Inc
BPTH
$29K ﹤0.01%
960
+30
+3% +$1.31K
EBET
3897
DELISTED
EBET, INC. Common Stock
EBET
$29K ﹤0.01%
1,520
+896
+144% +$20.7K
AEMD icon
3898
Aethlon Medical
AEMD
$351K
$28K ﹤0.01%
25
+9
+56% +$16.4K
ALZN icon
3899
Alzamend Neuro
ALZN
$6.42M
$28K ﹤0.01%
+37
New +$53.6K
CLPS icon
3900
CLPS Inc
CLPS
$26.9M
$28K ﹤0.01%
24,932
+11,100
+80% +$13.4K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.